Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jiwu2573
    Member
    • Jun 2009
    • 34

    #31
    Another question is about samples size.

    I have 2 groups with case and control (paired or unpaired). Samples in each group are from different individuals. I get about 10-13 million reads/sample with 76 bp read length.

    How many individuals do I need for each group to get reliable statistics? Such as power and significant DE genes.

    Do I better off have balanced group (case number = control number) or I can have, say 13 cases and 7 controls instead?

    Comment

    • Xi Wang
      Senior Member
      • Oct 2009
      • 317

      #32
      Originally posted by jiwu2573 View Post
      Hi Xi,

      The samWrapper also works well. But I am a bit confused about the column designation.

      When I looked at the output "gene.exp", 1st col gives the gene ID, 2nd col for raw counts, 3rd col for RPKM, and 4th for all reads, then the pattern keeps on repeating for each sample. In this order, expCol1 should be col 2 and 5 (raw counts columns), but how comes 2 and 4 as you wrote?

      Also I don't understand measure1 or measure2. What's the use of them? By the way, my samples are unpaired.
      Sorry, I have not tested the code. I think you understand the usage of samWrapper, go ahead to use it.

      I am sorry again I did not notice your samples are not paired. So you may use
      Code:
      measure1=rep(1, length(expCol1)),
      measure2=rep(2, length(expCol2)),
      paired=FALSE
      It's also the default.
      Xi Wang

      Comment

      • Xi Wang
        Senior Member
        • Oct 2009
        • 317

        #33
        Originally posted by jiwu2573 View Post
        Another question is about samples size.

        I have 2 groups with case and control (paired or unpaired). Samples in each group are from different individuals. I get about 10-13 million reads/sample with 76 bp read length.

        How many individuals do I need for each group to get reliable statistics? Such as power and significant DE genes.

        Do I better off have balanced group (case number = control number) or I can have, say 13 cases and 7 controls instead?
        If you have few samples, the more the better. And I also think the balanced groups and even paired samples are much better.
        Xi Wang

        Comment

        • jiwu2573
          Member
          • Jun 2009
          • 34

          #34
          Hi Xi,

          Can you suggest a minimum sample size that is normally acceptable for DEGSeq?

          Comment

          • Xi Wang
            Senior Member
            • Oct 2009
            • 317

            #35
            Originally posted by jiwu2573 View Post
            Hi Xi,

            Can you suggest a minimum sample size that is normally acceptable for DEGSeq?
            I thinks 5 vs 5 case-control samples are ok. There is a tradeoff between the cost and the statistical power to convince others.
            Xi Wang

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              Yesterday, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 10:52 AM
            0 responses
            8 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 05:39 AM
            0 responses
            17 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            15 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...